Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hamilton Thorne Ltd T.HTL

Alternate Symbol(s):  HTLZF

Hamilton Thorne Ltd. is a provider of precision instruments, consumables, software and services to assisted reproductive technologies (ART), research, and cell biology markets. The Company markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, Microptic, and Embryotech Laboratories brands. It also provides an array of third-party equipment and consumables to meet customer requirements. Its branded instrument, equipment and software product lines include precision laser devices, imaging systems, incubators, laminar flow workstations, air purification systems, control rate freezers, lab monitoring systems, and micromanipulation systems. It also offers a portfolio of artificial intelligence (AI)-enabled common astronomy software applications (CASA) software and other product offerings. Its GM501 family of products provides the in vitro fertilization (IVF) lab with comprehensive cell culture media solutions.


TSX:HTL - Post by User

Bullboard Posts
Comment by bigreturn11on Nov 20, 2017 4:49pm
111 Views
Post# 26999185

RE:Insight: volume increase & price stickiness

RE:Insight: volume increase & price stickiness

Probably further tax loss selling for those that got in at $1 or more and rode the stock market highs, now needing the loss to offset other gains. Lots of interested buyers at this rate. I've been buying at these levels for a couple of weeks now. You're looking at one of the cheapest junior tech stocks in North America based on forward earnings. 

Look for record revenue and profit on the Q report coming out this evening or tomorrow morning.  Conference call is tomorrow at 11 am EST.

The IVF market should grow organically by over 30% by 2022.  The CEO has a track record of acquisitions and is well connected in this space.  He has done 40 acquisitions in the last 20 years.  I fully expect revenues to triple in the next 5 years through organic growth and acquisition. This is a high margin business and HTL is a renowned leader in the sector.  

Excellent analyst coverage.


Bullboard Posts